probiotix health Regulatory News (PBX.PL)

ProBiotix Health plc

("ProBiotix" or the "Company")

New appointment

ProBiotix Health plc (AQUIS: PBX), a life sciences business developing probiotics to support cardiometabolic health, announces that Mads Brandt has joined the Company as Global Supply Chain Director. Mads's appointment became effective from 1 December 2023, and is part of the Company's strategy to bring experts on board to support the future growth plans for the Company.

Mads has over 20 years' experience in working in the supply chain space, and has a broad understanding of logistics, management consultancy and operations. He is driven by his leadership skills and vast expertise in the medical device, pharma and medtech industries. He has previously worked for a number of global organisations such as ISS A/S, PA Consulting Group and LEO Pharma where he held various key senior management positions.

Steen Andersen, CEO of ProBiotix Health plc commented: "On behalf of the team at ProBiotix, I would like to welcome Mads as our new Global Supply Chain Director and I know he will be a great asset to the Company. He brings an extensive skillset in the supply chain field, which can help greatly in supporting operational, tactical and strategical aspects of operations at a global scale.

"With his considerable experience, he can help us to build and optimise our supply chain, improve on and capitalise on our partnerships with existing and potentially new CMO's, creating an agile and stable supply chain to create a platform for growth and help us to plan our future with efficiency. He will allow us to be even more innovative in our approach to product solutions to cater for our customer and market needs."

For further information, please contact:

Market Abuse Regulation (MAR) Disclosure

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation EU 596/2014 as it forms part of retained EU law (as defined in the European Union (Withdrawal) Act 2018).